Table 2

Symptoms reported by study subjects experiencing ILI by HIV status

HIV+HIV−P value
Moderate–severe symptoms n=50 (%) n=460 (%)
Fatigue49 (98)387 (84) 0.01
Muscle pain38 (76)316 (69)0.37
Cough38 (76)371 (81)0.55
Chills37 (74)371 (81)0.35
Reduced appetite36 (72)295 (64)0.34
Sore throat35 (70)334 (73)0.82
Headache32 (64)318 (69)0.56
Joint pain30 (60)297 (65)0.63
Hoarseness30 (60)250 (54)0.54
Runny nose30 (60)317 (69)0.26
Diarrhea25 (50)96 (21) <0.001
Sneezing21 (42)205 (45)0.84
Itchy eyes18 (36)150 (33)0.74
Dizziness19 (38)139 (30)0.33
Shortness of breath18 (36)158 (34)0.94
Earache14 (28)153 (33)0.55
Nausea15 (30)137 (30)1.00
Abdominal pain12 (24)104 (23)0.96
Chest pain8 (16)134 (29)0.07
Vomiting6 (12)67 (15)0.78
  • Individual symptoms were recorded as none, mild, moderate or severe, generally for 7+ days post-ILI onset (90% of subjects recorded at least 7 days with symptom data). The values reported here are the number (%) of individuals who reported moderate or severe symptoms at any time during the episode. χ2 and t-test were used to calculate p values. P values were considered statistically significant at <0.05 (in bold).

  • ILI, influenza-like illness.